Gene and Cell Therapy
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section of Biomedicines aims to rapidly publish contributions on all aspects of the latest research results concerning gene and cell therapy. We encourage the submission of manuscripts that provide novel and mechanistic insights and papers that report significant advances on the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Phenotypic Consequences of Human Genetic Diversity (Deadline: 30 April 2024)
- Virotherapy and Gene Therapy in Cancer (Deadline: 15 May 2024)
- Osteoarthritis: Molecular Pathways and Novel Therapeutic Strategies (Deadline: 31 May 2024)
- Regulatory T Lymphocytes: Three Decades with Odette-and-Odile in Human Diseases (Deadline: 31 May 2024)
- Advances in CAR-T Cell Therapy (Deadline: 31 May 2024)
- Advancements in Induced Pluripotent Stem Cells (Deadline: 31 July 2024)
- Vascular Malformation: From Pathophysiology, Clinical Manifestations to Novel Therapeutic Approaches (Deadline: 31 July 2024)
- Genetics of Chronic Disease (Deadline: 31 July 2024)
- Intersections between Neurodegeneration, Cancer and Aging: A Proteomics Perspective (Deadline: 30 September 2024)
- Galectin as Disease Biomarker (Deadline: 30 November 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
